[Nephrotic syndrome following methylmercaptoimidazole therapy].
D000328:Adult; D013956:Antithyroid Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy*; D007093:Imidazoles / Q000009:adverse effects*; D007668:Kidney / Q000473:pathology; D008713:Methimazole / Q000009:adverse effects; D009404:Nephrotic Syndrome / Q000139:chemically induced* / Q000188:drug therapy / Q000473:pathology; D011239:Prednisolone / Q000627:therapeutic use
D013956:Antithyroid Agents; D007093:Imidazoles; D008713:Methimazole; D011239:Prednisolone
Nephrotisches Syndrom nach Methylmercaptoimidazoltherapie.